Academic Journal
Q1Intestinal Research
About Intestinal Research
Intestinal Research is a scholarly journal published by Korean Association for the Study of Intestinal Diseases. SCImago 2025 lists it in Q1, with an SJR of 1.266 and H-index of 42.
Coverage: 2016-2026. Research categories: Gastroenterology (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Microplastics and inflammatory bowel disease: dissecting the evidence from observational links to potential causal mechanisms
Wei Si Soong, Lai Ti Gew, Jactty Chew, Norfilza Mohd Mokhtar et al.
2026-09-10 · DOI: 10.5217/ir.2025.00343Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study
Krishan S Patel, Butros Fakhoury, Kavin Parmar, Vinay Jahagirdar et al.
2026-09-10 · DOI: 10.5217/ir.2026.00152Development of liver cirrhosis during azathioprine therapy for inflammatory bowel disease
Jihye Park, Jae Seung Lee, Mi Na Kim, Soo Jung Park et al.
2026-09-10 · DOI: 10.5217/ir.2026.00051Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn’s disease: a 24-week multicenter study from China
Zile Zhang, Shuowen Zhang, Wensong Ge, Yue Li et al.
2026-09-04 · DOI: 10.5217/ir.2026.00114Chinese expert consensus on extraintestinal manifestations of inflammatory bowel disease
Jie Liang, Liuqing Zhao, Jun Shen, Hong Yang et al.
2026-08-10 · DOI: 10.5217/ir.2026.00147Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease
Jee Hyun Kim, Yoon Jeong Choi, Jun Hwan Yoo
2026-08-10 · DOI: 10.5217/ir.2026.00013Real-world data on the effectiveness of risankizumab as induction therapy for ustekinumab-refractory ulcerative colitis
Ryo Morikawa, Toshimitsu Fujii, Akiko Tamura, Ami Kawamoto et al.
2026-08-10 · DOI: 10.5217/ir.2025.00338Integrating perspectives on transabdominal intestinal ultrasound in inflammatory bowel disease management: a nationwide cross-sectional survey of physicians and patients in China
Longxi Yun, Zhaojue Wang, Yujun Chen, Ning Chen et al.
2026-07-30 · DOI: 10.5217/ir.2025.00074Analysis of gut microbiota in super donors for fecal microbiota transplantation and isolated gut commensal bacteria of inhibition against <i>Clostridioides difficile</i>
Ki Sung Kang, Gee Hyeun Choi, Yu Jin Kim, Won Suk Lee et al.
2026-07-30 · DOI: 10.5217/ir.2025.00179Evolution of surgical trends in Crohn’s disease during the biologic era: population-based cohort insights from Taiwan, a low-endemicity region
Er-Hsiang Yang, Nai-Yu Chen, Ching-Lan Cheng, Yu-Ching Chang et al.
2026-07-30 · DOI: 10.5217/ir.2025.00003Population-based screening colonoscopy in Korea: balancing benefits and limitations
Hyoung Il Choi, Jae Myung Cha
2026-07-30 · DOI: 10.5217/ir.2025.00188Venous thromboembolism prophylaxis in pregnant women with inflammatory bowel disease: evidence gaps and future directions from the KASID Guidelines Task Force Team
Jiyoung Yoon, Eun Mi Song, Dong Hyun Kim, Young Joo Yang et al.
2026-07-30 · DOI: 10.5217/ir.2026.00128A survey on the practices and patterns in the management of acute severe ulcerative colitis in India
Arshia Bhardwaj, Arshdeep Singh, Riya Sharma, Vandana Midha et al.
2026-07-30 · DOI: 10.5217/ir.2025.00060Real-world effectiveness and safety of upadacitinib in Korean patients with inflammatory bowel disease: a single-center retrospective study
Ji Eun Kim, Yeong Chan Lee, Minjee Kim, Eun Ran Kim et al.
2026-07-30 · DOI: 10.5217/ir.2025.00235Escalation to biologics after corticosteroids in patients with newly diagnosed Crohn’s disease in Japan: a claims analysis from 2010 to 2021
Minoru Matsuura, Annabelle Yoon, Jun Miyoshi, Tadakazu Hisamatsu et al.
2026-07-30 · DOI: 10.5217/ir.2025.00059Upadacitinib in Asian inflammatory bowel disease practice: encouraging real-world efficacy
Eun Soo Kim
2026-07-30 · DOI: 10.5217/ir.2026.00200Evidence-based clinical practice guidelines for diagnosis and medical management of acute colonic diverticulitis developed by the Korean Association for the Study of Intestinal Diseases (KASID)
Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song et al.
2026-07-30 · DOI: 10.5217/ir.2025.00299Comments on “Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study”
Philippe Pinton
2026-07-30 · DOI: 10.5217/ir.2025.00234Preventive and therapeutic effects of co-administration of <i>Bacteroides thetaiotaomicron</i> and infliximab on dextran sodium sulfate-induced colitis in mice
Sara Ahmadi Badi, Hamid Reza Moradi, Ahmad Berimipour, Shima Shojaie et al.
2026-07-30 · DOI: 10.5217/ir.2025.00061Fecal surrogate markers strongly correlate with endoscopic findings in pediatric onset inflammatory bowel disease: a retrospective study in Japan
Ryoko Yoshimura, Takahiro Kudo, Masanori Toda, Kosuke Kashiwagi et al.
2026-07-30 · DOI: 10.5217/ir.2025.00103Reviews
Community Reviews
Version History
September 25, 2026 at 7:40 am
September 25, 2026